Table S3 from Transcriptome Analysis of Matched Cohorts of Long- and Short-term Survivors in Advanced High-grade Serous Tubo-ovarian Cancer

This is a Quantitative Study study.

Key Points

Analysis shows differing subtype likelihoods for long-term and short-term survivors in tubo-ovarian cancer.
Table S3 estimates likelihoods using ConsensusOV for various subtypes, critical for targeted treatment approaches.
The study employed transcriptome analysis methods to investigate gene expression differences in cancer survival types.
These findings may enable personalized therapies based on subtype differentiation in advanced cancer cases.

Analysis reveals subtype likelihoods in advanced high-grade serous tubo-ovarian cancer survivors, highlighting distinctions between profiles.

Table S3 shows the likelihoods estimated by ConsensusOV for the subtypes of Charité STS and LTS.

No takes yet. Share an insight, caveat, or question.

Marchenko et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Share